News
CEO of Novo Nordisk, maker of Wegovy, is stepping down
Danish pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the company’s board of directors, citing “recent market challenges” and a steep decline in the company’s share price.
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
7h
The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...
When considering a weight loss medication — or any medication — it’s normal to wonder when the effects will kick in.
Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.
The usual dose of Novo Nordisk’s expensive weight-loss drug Wegovy can be cut in half without affecting the results, ...
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...
A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...
One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...
Obesity has long been one of America's most persistent and complex public health challenges. Despite the rise and fall of countless weight-loss fads and miracle diets, millions of people still find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback